VK

Virender Kumar Singh

Director DIN 01607547
DIN 01607547 First appointment May 2007
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since May 2007
Shareholding value β€’β€’β€’β€’ Premium profile

About Virender Kumar Singh

Data last updated:

Virender Kumar Singh was a Director at Morn Infratech Private Limited (from 2012) and Director at Bremen Basel Pharmaceuticals Private Limited (from 2007).

DIN 01607547
First Appointment 03 May 2007
Oldest Company Age 19 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Morn Infratech Private Limited U70100DL2012PTC235462
Director08 May 20122012Strike Off
Director03 May 20072007Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Morn Infratech Private Limited
Bremen Basel Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Virender Kumar Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Virender Kumar Singh

Virender Kumar Singh was first appointed on 03 May 2007 as Director at Bremen Basel Pharmaceuticals Private Limited. The most recent appointment on record is 08 May 2012 at Morn Infratech Private Limited.

Virender Kumar Singh held 2 earlier board appointments: Morn Infratech Private Limited (Director, from 08 May 2012); Bremen Basel Pharmaceuticals Private Limited (Director, from 03 May 2007).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available